Traumatic brain injury has lasting effect on sleep
Sleep–wake disturbances are a persistent problem in people who have sustained a traumatic brain injury and one that is underestimated by patients, study data indicate. (Source: MedWire News)
Source: MedWire News - April 28, 2016 Category: Consumer Health News Tags: Neurology Source Type: news
Serum marker may flag liver fibrosis in chronic HBV
Serum levels of Wisteria floribunda agglutinin-positive Mac-2-binding protein may reflect the severity of liver fibrosis in patients with chronic hepatitis B virus infection, say researchers. (Source: MedWire News)
Source: MedWire News - April 27, 2016 Category: Consumer Health News Tags: HBV Source Type: news
WFA+-M2BP levels linked to liver fibrosis, HCC progression in chronic HBV
Japanese researchers have found that serum levels of glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein are a useful marker of not only the degree of liver fibrosis, but also progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection. (Source: MedWire News)
Source: MedWire News - April 27, 2016 Category: Consumer Health News Tags: HBV Source Type: news
HBcrAg may predict HCC development
Research suggests a role for hepatitis B core-related antigen in the prediction of hepatocellular carcinoma development in nucleos(t)ide analogue treatment-naïve patients with chronic hepatitis B virus infection. (Source: MedWire News)
Source: MedWire News - April 27, 2016 Category: Consumer Health News Tags: HBV Source Type: news
Little and often gives exercise benefits in Type 2 diabetes
Sedentary, overweight adults with Type 2 diabetes can improve their cardiometabolic profile by engaging in very brief but regular periods of light walking or resistance exercise, research suggests. (Source: MedWire News)
Source: MedWire News - April 27, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
Anticholinergic medication use best avoided in older adults
Brain imaging techniques have shown negative effects of anticholinergic medications on brain metabolism and size in cognitively healthy adults, providing further insight into the increased risk of cognitive decline associated with these medications. (Source: MedWire News)
Source: MedWire News - April 27, 2016 Category: Consumer Health News Tags: Alzheimer ' s disease Source Type: news
Updated guidance on botulinum toxin formulations for four indications
The American Academy of Neurology has issued an update to its 2008 guidelines on the use of botulinum toxin for the treatment of spasticity, cervical dystonia, blepharospasm and migraine headache. (Source: MedWire News)
Source: MedWire News - April 26, 2016 Category: Consumer Health News Tags: Neurology Source Type: news
GLP-1 receptor agonist may benefit high-risk diabetes
Research shows that using a glucagon-like peptide-1 receptor agonist instead of a rapid-acting insulin analogue at mealtimes can reduce glycaemic variability in high-risk patients with Type 2 diabetes. (Source: MedWire News)
Source: MedWire News - April 26, 2016 Category: Consumer Health News Tags: Diabetes Source Type: news
Rituximab outperforms fingolimod after natalizumab switch
Rituximab is more effective and better tolerated than fingolimod for patients with multiple sclerosis needing to switch from natalizumab due to JC-virus antibody positivity, research suggests. (Source: MedWire News)
Source: MedWire News - April 26, 2016 Category: Consumer Health News Tags: Multiple sclerosis Source Type: news
Meta-analysis supports combination therapy for PAH patients
A meta-analysis shows that clinical worsening is significantly less likely in patients with pulmonary arterial hypertension if they are given combination treatment, rather than monotherapy. (Source: MedWire News)
Source: MedWire News - April 25, 2016 Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news
UK research allays fears over dramatic increases in dementia incidence
Research conducted in the UK has found a 20% drop in the incidence of dementia over the past 2 decades, leading to an estimated 41,000 fewer cases per year in people aged 65 years and older than previously expected. (Source: MedWire News)
Source: MedWire News - April 22, 2016 Category: Consumer Health News Tags: Alzheimer ' s disease Source Type: news
Bosutinib shows ‘low’ vascular, cardiac event risk profile
Third-generation tyrosine kinase inhibitor study findings suggest that bosutinib is associated with a low risk of vascular and cardiac events in patients undergoing first-line or subsequent treatment for chronic myeloid leukaemia. (Source: MedWire News)
Source: MedWire News - April 22, 2016 Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news
BCR–ABL halving time indicates CML prognosis during front-line TKI
Calculating halving time of the BCR–ABL transcript after 3 months may help determine prognosis in chronic myeloid leukaemia patients undergoing first-line tyrosine kinase inhibitor therapy, say researchers. (Source: MedWire News)
Source: MedWire News - April 22, 2016 Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news
Prompt attention may limit recurrence risk in TIA patients
Centres with procedures in place for the rapid assessment of patients with transient ischaemic attack or minor stroke achieve low recurrence rates in these patients, a multinational study shows. (Source: MedWire News)
Source: MedWire News - April 21, 2016 Category: Consumer Health News Tags: Stroke Source Type: news
Additional chromosomal abnormalities prognostic for CML
Additional chromosomal abnormalities can be used to create two prognostic groups of patients with chronic myeloid leukaemia, suggests research published in Blood. (Source: MedWire News)
Source: MedWire News - April 20, 2016 Category: Consumer Health News Tags: Chronic myeloid leukaemia Source Type: news
